Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2009-10-22

Clinical Trial Update: Assessing Efficacy and Safety of Lacosamide Compared to Placebo in Reducing Signs and Symptoms of Fibromyalgia Syndrome. [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the efficacy and safety of lacosamide versus placebo for reducing signs and symptoms of fibromyalgia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Vimpat (lacosamide)

Snippet

Sponsor: UCB Pharma | Conditions: Fibromyalgia Syndrome | Phase 2 | Status: COMPLETED | Results posted: 2009-10-22